Top Markets
#1 Cortex Cortex +33.66%
#2 Seeker Seeker +20.06%
#3 Official Trump Official Trump +9.41%
#4 Ethena Staked ENA Ethena Staked ENA +9.25%
#5 EXOD EXOD +9.04%
#6 peaq peaq +8.30%
#7 Wrapped Aave Ethereum WETH Wrapped Aave Ethereum WETH +7.70%
#8 MarsCoin MarsCoin +7.36%
#9 Solstice Solstice +6.35%
#10 Versatize Coin Versatize Coin +5.26%
Coin of the day
Cortex Cortex
Settings
Language
ENGLISH
Currency
USD
Theme
BELLUS Health Inc. BELLUS Health Inc.

BELLUS Health Inc.

BLU
Rank in Stocks #6891
BELLUS Health Inc. is a biopharmaceutical firm in the clinical development... BELLUS Health Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to creating new therapeutic options for intractable chronic cough (RCC) and various other conditions characterized by heightened cough sensitivity. The company's primary investigational compound, BLU-5937, functions as a P2X3 receptor antagonist. This drug is currently progressing through Phase II clinical trials, where it is being assessed for its potential in treating both RCC and persistent itching. Founded in 1993, BELLUS Health Inc. is headquartered in Laval, Canada.
Share Price
$14.30
Last synced: 2023-06-29
Market Cap
$1.81B
Change (1 day)
-2.81%
Change (1 year)
0.00%
Country
CA
Trade BELLUS Health Inc. (BLU)

Category

Healthcare
EPS for BELLUS Health Inc. (BLU)
EPS as of 2026 TTM: 0
According to BELLUS Health Inc. latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for BELLUS Health Inc. from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors
Company EPS EPS Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH